IBIO: iBio, Inc. Growth-Adjusted Market Cap to Net Income
iBio, Inc. (IBIO) is developing an AI system for antibody discovery, helping pharma behemoths reduce R&D costs. Tracking the PEG ratio visualizes the dynamics of this value, where the 0.00 mark reflects the latest data. High barriers to entry are created by protein synthesis patents. However, reliance on contracts and the pre-commercial status of the RubrY platform determine the asset's ultimate risks and potential.
Metric breakdowns and analytics for iBio, Inc. (IBIO)
- share price and consensus valuation forecast:
- market capitalization information:
- company book value details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
IBIO - Net Profit|Company Profit Forecast iBio, Inc.|IBIO - Price to Earnings Ratio|Projected Price to Earnings Ratio iBio Corporation|IBIO - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation iBio Corp|IBIO - Operating profit EBITDA|Net earnings per share for the last four quarters iBio|IBIO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months ibioinc.com|IBIO - Earnings growth in current year|Expected earnings per share growth for next year iBio, Inc.
General company analysis:IBIO - iBio Inc
Long-term asset screening requires aligning market value with earnings dynamics. This ratio divides P/E by the EPS growth rate to determine whether the price is fair relative to business expansion. The sustainability of iBio, Inc. (IBIO) plant-based expression systems could serve as a catalyst for this growth. By analyzing the growth-normalized P/E, an investor can identify fundamental undervaluation, where values below one signal high return potential.
Competing companies
ARGX (argenx N.V.) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (BioNTech Group)|Growth-Adjusted Market Cap to Net Income Abivax (ABVX)|ADMA - Price/Earnings to Growth Ratio|protagonist-inc.com (PTGX) - Price/Earnings to Growth Multiple|Immunovant (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals, Ltd.|Price/Earnings to Growth Multiple GRFS|PEG Multiple Adaptive Biotechnologies Inc.|Price/Earnings to Growth Ratio Celldex Therapeutics (CLDX)|auriniapharma.com - Growth-Adjusted P/E Ratio|PEG Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Price to Earnings Adjusted for Growth Rate|Dianthus Pharma - PEG Multiple|Growth-Adjusted Market Cap to Net Income Pharvaris Pharma PHVS|ABCL: PEG Multiple|TRML (tourmalinebio.com) - Price/Earnings to Growth Ratio|PGEN (Precigen) - PEG Multiple|Pharming Group NV (PHAR) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Nektar (NKTR)|UPB - Price to Earnings Adjusted for Growth Rate|Zenas Biopharma Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio IMNM|Gossamer Bio - PEG Multiple|Growth-Adjusted Market Cap to Net Income KalVista Pharma KALV|Septerna Corp (SEPN) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio PVLA|SVRA (Savara Inc.) - PEG Multiple|Price/Earnings to Growth Multiple rigel.com (RIGL)|Price/Earnings to Growth Multiple ANAB (AnaptysBio)|Growth-Adjusted Market Cap to Net Income Astria Therapeutics Inc|PEG Multiple ENGN (enGene Bio)|Growth-Adjusted Market Cap to Net Income rapt.com (RAPT)|Aerovate - PEG Multiple|ACRS: Price/Earnings to Growth Ratio|KYTX: PEG Multiple|TLSA - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Cabaletta Bio, Inc|Price to Earnings Adjusted for Growth Rate Ventyx Biosciences, Inc VTYX|Price/Earnings to Growth Ratio Theratechnologies Inc. (THTX)|AVTX: Market Cap to Earnings and Growth Ratio|PEG Multiple ELDN (Eledon Pharmaceuticals, Inc.)|Growth-Adjusted Payback Ratio AGEN|Climb Bio, Inc. - PEG Multiple|ZURA - PEG Multiple|aTyr Pharma, Inc. (ATYR) - Price/Earnings to Growth Ratio|Adagene Inc. - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio ImageneBio|Price/Earnings to Growth Multiple Shattuck Therapeutics (STTK)|PEG Multiple EQ|PEG Multiple connectbiopharm.com (CNTB)|Immunic - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ATRA|InflaRx GmbH - PEG Multiple|Growth-Adjusted Market Cap to Net Income X4 Pharmaceuticals Inc. XFOR|adicetbio.com (ACET) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Celularity|Price/Earnings to Growth Ratio INmune Bio, Inc.|Price/Earnings to Growth Multiple barinthusbio.com (BRNS)|Price/Earnings to Growth Multiple KZR (Kezar Life Sciences, Inc.)|PEG Multiple SAB Biotherapeutics Inc. (SABS)|Price/Earnings to Growth Ratio Akari Therapeutics plc AKTX|ENLV: Growth-Adjusted P/E Ratio|Q32 Bio Corp - PEG Multiple|Price to Earnings Adjusted for Growth Rate geovax.com|EDSA: PEG Multiple|CARM - Growth-Adjusted Market Cap to Net Income|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG Multiple|Price/Earnings to Growth Ratio BOLT|PEG Multiple HCWB|Growth-Adjusted Market Cap to Net Income aptevotherapeutics.com|Price/Earnings to Growth Ratio AIM ImmunoTech AIM|Aditxt Inc. (ADTX) - Price to Earnings Adjusted for Growth Rate|GRI: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio XRTX (XORTX Corp)|HIND: PEG Multiple|REVB - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Indaptus Therapeutics, Inc.|Growth-Adjusted P/E Ratio SCNI (Scinai Immunotherapeutics Ltd)|PEG Multiple CALI|Price/Earnings to Growth Multiple affimed.com AFMD|Allakos - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - PEG Multiple|Growth-Adjusted Market Cap to Net Income iTeos Therapeutics Inc ITOS|OCEA: PEG Multiple|TCBP (TC BioPharm Ltd) - Price/Earnings to Growth Ratio|THRD (Third Harmonic Bio) - PEG Multiple
